MGMT and glioblastoma: Furthermore, the patients of WHO 2-3 (recurrent WHO 2, AA WHO), WHO 4 (GBM), IDH status, MGMT methylation status and 1p19q non-co-deletion in high-risk had poor prognosis in CGGA simultaneously.